Published in PLoS One on April 11, 2012
Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip (2013) 1.50
On being the right size: scaling effects in designing a human-on-a-chip. Integr Biol (Camb) (2013) 1.23
Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure. Exp Biol Med (Maywood) (2014) 0.93
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs. Sci Rep (2016) 0.89
Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. Sci Rep (2017) 0.85
Supplementation with the extract of schisandrae fructus pulp, seed, or their combination influences the metabolism of lipids and glucose in mice fed with normal and hypercholesterolemic diet. Evid Based Complement Alternat Med (2014) 0.81
Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. Technology (Singap World Sci) (2015) 0.81
Allometric Scaling and Cell Ratios in Multi-Organ in vitro Models of Human Metabolism. Front Bioeng Biotechnol (2014) 0.77
Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions. Tissue Eng Part B Rev (2016) 0.75
In silico models for dynamic connected cell cultures mimicking hepatocyte-endothelial cell-adipocyte interaction circle. PLoS One (2014) 0.75
Tissue chips - innovative tools for drug development and disease modeling. Lab Chip (2017) 0.75
Building an experimental model of the human body with non-physiological parameters. Technology (Singap World Sci) (2017) 0.75
The hepatocyte proteome in organotypic rat liver models and the influence of the local microenvironment. Proteome Sci (2017) 0.75
Integrated Gut/Liver Microphysiological Systems Elucidates Inflammatory Inter-Tissue Crosstalk. Biotechnol Bioeng (2017) 0.75
A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab (2009) 11.46
Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol (2005) 8.39
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J (2008) 4.74
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA (2004) 3.69
Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature (2008) 3.31
Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem (1978) 2.93
Cell-cell and intracellular lactate shuttles. J Physiol (2009) 2.48
Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes (2011) 2.08
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation (2009) 2.00
Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology (1995) 1.77
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2007) 1.61
The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab (2006) 1.44
Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol (2011) 1.41
Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev (2002) 1.30
Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab (2009) 1.29
Cellular models for understanding adipogenesis, adipose dysfunction, and obesity. J Cell Biochem (2010) 1.09
Mechanism of control of hepatic glycogenesis by insulin. J Biol Chem (1973) 1.08
Metabolic and health complications of obesity. Dis Mon (1990) 1.07
Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun (1996) 1.04
Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J Biol Chem (2000) 1.01
Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord (2002) 0.99
A low shear stress modular bioreactor for connected cell culture under high flow rates. Biotechnol Bioeng (2010) 0.98
Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest (1996) 0.97
Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med (2006) 0.96
Fatty acid transport and metabolism in HepG2 cells. Am J Physiol Gastrointest Liver Physiol (2005) 0.94
Study of the crosstalk between hepatocytes and endothelial cells using a novel multicompartmental bioreactor: a comparison between connected cultures and cocultures. Tissue Eng Part A (2009) 0.94
SERPINB3 modulates TGF-beta expression in chronic liver disease. Lab Invest (2010) 0.91
Glucose and insulin regulate insulin sensitivity in primary cultured adipocytes without affecting insulin receptor kinase activity. Endocrinology (1991) 0.89
Glucose-dependent insulin modulation of oscillatory lipolysis in perifused rat adipocytes. Obes Res (2005) 0.89
Modular bioreactor for primary human hepatocyte culture: medium flow stimulates expression and activity of detoxification genes. Biotechnol J (2011) 0.89
In vitro liver model using microfabricated scaffolds in a modular bioreactor. Biotechnol J (2010) 0.88
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. Diabetes Obes Metab (2011) 0.88
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. J Endocrinol Invest (1996) 0.88
High glucose-treated macrophages augment E-selectin expression in endothelial cells. J Biol Chem (2011) 0.87
Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. Biochem Biophys Res Commun (2006) 0.86
Metabolic control through hepatocyte and adipose tissue cross-talk in a multicompartmental modular bioreactor. Tissue Eng Part A (2011) 0.84
Elastase activity enhances the adhesion of neutrophil and cancer cells to vascular endothelial cells. J Surg Res (2000) 0.84
Potentiation by glucose of lipolytic responsiveness of human adipocytes. Diabetes (1986) 0.83
Flow-regulated glucose and lipid metabolism in adipose tissue, endothelial cell and hepatocyte cultures in a modular bioreactor. Biotechnol J (2010) 0.83
A flexible bioreactor system for constructing in vitro tissue and organ models. Biotechnol Bioeng (2011) 0.83
Release of soluble E-selectin from activated endothelial cells upon apoptosis. Lung (2007) 0.82
Protein metabolism in diabetes mellitus. Baillieres Clin Endocrinol Metab (1996) 0.81
Sympathetic stimulation of ischemic myocardium: role of plasma free fatty acids and potassium. J Cardiovasc Pharmacol (1988) 0.78
Depot-dependent effects of adipose tissue explants on co-cultured hepatocytes. PLoS One (2011) 0.78
Effect of insulin on free fatty acid uptake by hepatocytes in the duck. J Endocrinol (1984) 0.77
Glucose as a lipolytic agent: studies on isolated rat adipocytes. Physiol Res (2000) 0.76
Global gene expression in Staphylococcus aureus biofilms. J Bacteriol (2004) 4.46
Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol (2005) 3.64
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol (2010) 3.48
Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J Bacteriol (2004) 3.45
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes (2012) 3.40
Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol (2005) 2.75
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol (2006) 2.51
Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology (2006) 2.36
Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin. J Bacteriol (2006) 2.32
Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol (2009) 2.31
Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol (2003) 2.28
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care (2013) 2.26
Transcription Profiling of the mgrA Regulon in Staphylococcus aureus. J Bacteriol (2006) 2.08
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. J Clin Endocrinol Metab (2010) 2.05
AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob Agents Chemother (2003) 1.98
Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol (2004) 1.96
Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives. J Bacteriol (2006) 1.89
A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother (2005) 1.88
Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J Bacteriol (2005) 1.85
Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis (2008) 1.79
Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. Diabetes Technol Ther (2013) 1.71
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine (2010) 1.67
MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother (2007) 1.65
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes (2013) 1.65
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care (2010) 1.60
Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care (2012) 1.57
Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis (2009) 1.57
A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet (2004) 1.56
Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J (2006) 1.50
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes (2010) 1.48
Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke (2006) 1.47
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol (2007) 1.44
Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis (2007) 1.44
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care (2010) 1.43
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res (2011) 1.41
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine (2011) 1.40
Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins. J Bacteriol (2006) 1.39
Comments on the article "Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations" by Marfella et al.: (Journal of Diabetes and Its Complications 24 [2010] 79-83). J Diabetes Complications (2011) 1.39
Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086. J Biol Chem (2008) 1.38
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation (2005) 1.37
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis (2009) 1.35
Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center. J Diabetes Sci Technol (2012) 1.35
Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vascul Pharmacol (2011) 1.34
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care (2013) 1.32
Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care (2007) 1.29
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol (2008) 1.27
Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells (2006) 1.25
Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis (2006) 1.22
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide. Vaccine (2009) 1.22
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens (2006) 1.20
Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther (2010) 1.16
Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care (2012) 1.16
Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. Eur J Neurosci (2007) 1.16
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care (2008) 1.14
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke (2007) 1.12
Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol (2009) 1.11
Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab (2004) 1.11
Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit. Am J Physiol Endocrinol Metab (2005) 1.10
Criticality of the biological and physical stimuli array inducing resident cardiac stem cell determination. Stem Cells (2008) 1.10
Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients. Acta Diabetol (2013) 1.10
Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One (2010) 1.09
Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabetes Care (2006) 1.08
Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis. J Infect Dis (2012) 1.08
Diabetic gait and posture abnormalities: a biomechanical investigation through three dimensional gait analysis. Clin Biomech (Bristol, Avon) (2009) 1.06
Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes (2005) 1.05
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev (2013) 1.05
Fabrication of PLGA scaffolds using soft lithography and microsyringe deposition. Biomaterials (2003) 1.05
First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care (2014) 1.05
Glucose variability: An emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract (2013) 1.05
NETosis is induced by high glucose and associated with type 2 diabetes. Acta Diabetol (2014) 1.04
Corneal diabetic neuropathy: a confocal microscopy study. J Refract Surg (2006) 1.02
Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol (2010) 1.02
A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes. Obesity (Silver Spring) (2006) 1.02
Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes (2010) 1.02
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol (2012) 1.00
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther (2014) 0.99
Endothelial progenitor cells and the diabetic paradox. Diabetes Care (2006) 0.99
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. Diabetes (2002) 0.99
At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell (2010) 0.98
Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr Diabetes Rev (2005) 0.98
Genipin-crosslinked chitosan/gelatin blends for biomedical applications. J Mater Sci Mater Med (2007) 0.96
Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond. Atherosclerosis (2013) 0.95
It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications. Exp Diabetes Res (2012) 0.94
Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma. Acta Ophthalmol (2009) 0.94
The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis (2007) 0.94
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp Diabetes Res (2012) 0.93
Endothelial progenitor cells in diabetes mellitus. Biofactors (2012) 0.93
Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa. Vaccine (2010) 0.93
Multinight "bedside" closed-loop control for patients with type 1 diabetes. Diabetes Technol Ther (2015) 0.93
Oral amino acids in elderly subjects: effect on myocardial function and walking capacity. Gerontology (2005) 0.92